Skip to main content
PMC home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1997 Mar;22(2):99–104.

Substance abuse and cognitive functioning in schizophrenia.

J Addington 1, D Addington 1
PMCID: PMC1188831  PMID: 9074303

Abstract

Individuals with schizophrenia have an increased vulnerability to abuse drugs or alcohol. This vulnerability can interfere with the course and treatment of the disorder and may also have a detrimental effect on already compromised cognitive functioning. This study has a matched, cross-sectional design and compares the social and cognitive functioning and the symptoms of 33 schizophrenia subjects who abuse substances with 33 nonabusing schizophrenia subjects. Subjects were matched on sex, age, and education variables and were all outpatients. Measures of social functioning and quality of life were used. Assessment of cognitive functioning included measures of verbal ability, attention, executive functioning, and verbal and visual memory. Substance-abusing subjects had significantly lower quality of life. There were no other differences between the 2 groups. Several explanations are offered for the lack of observed differences in cognitive functioning.

Full text

PDF
99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arndt S., Tyrrell G., Flaum M., Andreasen N. C. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment. Psychol Med. 1992 May;22(2):379–388. doi: 10.1017/s0033291700030324. [DOI] [PubMed] [Google Scholar]
  2. Bartels S. J., Teague G. B., Drake R. E., Clark R. E., Bush P. W., Noordsy D. L. Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis. 1993 Apr;181(4):227–232. doi: 10.1097/00005053-199304000-00003. [DOI] [PubMed] [Google Scholar]
  3. Birchwood M., Smith J., Cochrane R., Wetton S., Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990 Dec;157:853–859. doi: 10.1192/bjp.157.6.853. [DOI] [PubMed] [Google Scholar]
  4. Cleghorn J. M., Kaplan R. D., Szechtman B., Szechtman H., Brown G. M., Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. J Clin Psychiatry. 1991 Jan;52(1):26–30. [PubMed] [Google Scholar]
  5. Dixon L., Haas G., Weiden P. J., Sweeney J., Frances A. J. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 1991 Feb;148(2):224–230. doi: 10.1176/ajp.148.2.224. [DOI] [PubMed] [Google Scholar]
  6. Drake R. E., Osher F. C., Wallach M. A. Alcohol use and abuse in schizophrenia. A prospective community study. J Nerv Ment Dis. 1989 Jul;177(7):408–414. doi: 10.1097/00005053-198907000-00004. [DOI] [PubMed] [Google Scholar]
  7. Eckardt M. J., Stapleton J. M., Rawlings R. R., Davis E. Z., Grodin D. M. Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age. Am J Psychiatry. 1995 Jan;152(1):53–59. doi: 10.1176/ajp.152.1.53. [DOI] [PubMed] [Google Scholar]
  8. Heinrichs D. W., Hanlon T. E., Carpenter W. T., Jr The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr Bull. 1984;10(3):388–398. doi: 10.1093/schbul/10.3.388. [DOI] [PubMed] [Google Scholar]
  9. Kay S. R., Fiszbein A., Opler L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
  10. Lieberman J., Jody D., Geisler S., Vital-Herne J., Alvir J. M., Walsleben J., Woerner M. G. Treatment outcome of first episode schizophrenia. Psychopharmacol Bull. 1989;25(1):92–96. [PubMed] [Google Scholar]
  11. Mueser K. T., Yarnold P. R., Levinson D. F., Singh H., Bellack A. S., Kee K., Morrison R. L., Yadalam K. G. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990;16(1):31–56. doi: 10.1093/schbul/16.1.31. [DOI] [PubMed] [Google Scholar]
  12. Sevy S., Kay S. R., Opler L. A., van Praag H. M. Significance of cocaine history in schizophrenia. J Nerv Ment Dis. 1990 Oct;178(10):642–648. doi: 10.1097/00005053-199010000-00005. [DOI] [PubMed] [Google Scholar]
  13. el-Guebaly N., Hodgins D. C. Schizophrenia and substance abuse: prevalence issues. Can J Psychiatry. 1992 Dec;37(10):704–710. doi: 10.1177/070674379203701006. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES